HIV-Positive Liver Transplant Does not Alter the Latent Viral Reservoir in Recipients With Antiretroviral Therapy-Suppressed HIV

Sarah E. Benner, Xianming Zhu, Sarah Hussain, Sander Florman, Yolanda Eby, Reinaldo E. Fernandez, Darin Ostrander, Meenakshi Rana, Shane Ottmann, Jonathan Hand, Jennifer C. Price, Marcus R. Pereira, David Wojciechowski, Jacques Simkins, Valentina Stosor, Sapna A. Mehta, Saima Aslam, Maricar Malinis, Ghady Haidar, Allan MassieMelissa L. Smith, Jonah Odim, Megan Morsheimer, Thomas C. Quinn, Gregory M. Laird, Robert Siliciano, Ashwin Balagopal, Dorry L. Segev, Christine M. Durand, Andrew D. Redd*, Aaron A.R. Tobian

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The latent viral reservoir (LVR) remains a major barrier to HIV-1 curative strategies. It is unknown whether receiving a liver transplant from a donor with HIV might lead to an increase in the LVR because the liver is a large lymphoid organ. We found no differences in intact provirus, defective provirus, or the ratio of intact to defective provirus between recipients with ART-suppressed HIV who received a liver from a donor with (n = 19) or without HIV (n = 10). All measures remained stable from baseline by 1 year posttransplant. These data demonstrate that the LVR is stable after liver transplantation in people with HIV.

Original languageEnglish (US)
Pages (from-to)1274-1279
Number of pages6
JournalJournal of Infectious Diseases
Volume228
Issue number9
DOIs
StatePublished - Nov 1 2023

Funding

Financial support. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) (grant numbers 1R01AI120938, U01AI134591, U24AI143502, and U01AI138897); the National Institute of Diabetes, Digestive and Kidney Diseases (grant number 1R01DK131926); and the Division of Intramural Research, NIAID, National Institutes of Health. A special thank you to the organ donors, families, and recipients who made this study possible. We also thank Diane Brown, Natasha Watson, and the HOPE in Action laboratory and clinical trial teams for their hard work and assistance with this project. We thank Kristen Ritter, Mignot Mathias, Miriam Hays, and Hanna Marks for their work on sample processing and virologic testing with this project. We also thank Northwestern University, Leah Goudy, RN and Michelle Callegari; University of Miami School of Medicine, Isabel Vital and Lissettt Moni; University of Pittsbugh, Kailey Hughes Kramer; University of California San Diego, Phirum Nguyen and Jeff Mills; New York University Lagone Health, Rebecca Dieter PharmD; and Ochsner Health, Angela Smith, MBA. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) (grant numbers 1R01AI120938, U01AI134591, U24AI143502, and U01AI138897); the National Institute of Diabetes, Digestive and Kidney Diseases (grant number 1R01DK131926); and the Division of Intramural Research, NIAID, National Institutes of Health.

Keywords

  • HIV
  • HIV cure
  • latent viral reservoir
  • liver
  • organ transplant

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'HIV-Positive Liver Transplant Does not Alter the Latent Viral Reservoir in Recipients With Antiretroviral Therapy-Suppressed HIV'. Together they form a unique fingerprint.

Cite this